Are two drugs better than one? A review of combination therapies for hypertension

Yogita Rochlani, Mohammed Hasan Khan, Maciej Banach, Wilbert S. Aronow

Research output: Contribution to journalReview articlepeer-review

15 Scopus citations


Introduction: Current guidelines for pharmacotherapy briefly describe a role for combination antihypertensive therapy. However, guidance on whether combination therapy should be used at the time of initiating therapy or as add on, and the choice of combination therapy is scarce. Areas covered: Current literature suggests that intensive blood pressure control is the key to managing cardiovascular risk. Along with lifestyle management, pharmacotherapy is an central component in the treatment of hypertension. Here, we aim to review the pathophysiology of hypertension, rationale for using combination therapy, and the different combinations of antihypertensive drug classes that are available in the market. Papers from 1967 through 2016 listed on PubMed on this topic were reviewed. Expert opinion: Based on the review of the literature, combination antihypertensive therapies are more effective than monotherapy and are also well tolerated, safe and cost effective for treatment of hypertension. Further research is needed to help guide the choice of combination antihypertensive therapy in different patient populations based on age, gender, race and comorbidities.

Original languageEnglish (US)
Pages (from-to)377-386
Number of pages10
JournalExpert Opinion on Pharmacotherapy
Issue number4
StatePublished - Mar 4 2017
Externally publishedYes


  • Hypertension
  • antihypertensive drugs
  • cardiovascular disease
  • combination antihypertensive therapy

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'Are two drugs better than one? A review of combination therapies for hypertension'. Together they form a unique fingerprint.

Cite this